GIFT vs NBIX · rev $83.2M vs P/E 45, rev $1.77B
RDE, Inc. (GIFT) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
RDE, Inc. (GIFT) is a internet content & information company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported GIFT revenue for 2025-12-31 was $83.2M. Net income was -$10.5M. Revenue was down 6.5% from 2024-12-31 to 2025-12-31. GIFT currently screens at market cap $29.8M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
GIFT currently screens at market cap $29.8M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the GIFT and NBIX stock pages for the full models.
Not investment advice.